Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C3BS-CQR-1 (C-Cure) in Chronic Advanced Ischemic Heart Failure
NCT01768702Phase 3Completed
- Sponsor
- Celyad Oncology
- Start
- Nov 2012
- Primary completion
- Aug 2017
- Modality
- Stem Cell Therapies
- Countries
- 9
01
Overview
A Phase 3 trial of C-Cure in Ischemic Heart Failure (IHF), sponsored by Celyad Oncology. Started Nov 2012; status: completed.
02
Drugs
C-Cure
03
Conditions
Ischemic Heart Failure (IHF)
Beyond the preview
Go deeper on NCT01768702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01768702.